ATHEROSCLEROSIS OF EXTREMITIES

Clinical trials for ATHEROSCLEROSIS OF EXTREMITIES explained in plain language.

Never miss a new study

Get alerted when new ATHEROSCLEROSIS OF EXTREMITIES trials appear

Sign up with your email to follow new studies for ATHEROSCLEROSIS OF EXTREMITIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Common drug could be Game-Changer for millions with clogged leg arteries

Disease control Recruiting now

This large, late-stage trial is testing whether a low daily dose of an existing anti-inflammatory drug (colchicine) can prevent serious complications in people with symptomatic peripheral artery disease (PAD). It aims to see if the drug reduces the combined risk of heart attacks,…

Matched conditions: ATHEROSCLEROSIS OF EXTREMITIES

Phase: PHASE3 • Sponsor: Population Health Research Institute • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

ATHEROSCLEROSIS OF EXTREMITIES

Get alerted when new ATHEROSCLEROSIS OF EXTREMITIES trials appear

Common drug could be Game-Changer for millions with clogged leg arteries